World / Health & Beauty
BrainStorm Cell Therapeutics And Rutgers University Study Shows That Transplanting NTF Cells Improves The Recovery Of Spinal Cord Injury Rat Model
09.07.2008 08:17
medicalnewstoday.com
BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, has completed a preclinical study in collaboration with the W.M. Keck Center for Collaborative Neuroscience at Rutgers, The State University of New Jersey. The study conducted at the Keck Center was an effort to repair spinal cord injuries in animals through the transplantation of Brainstorm's neurotrophic factor (NTF) adult stem cells.
World
Neurology
Xclair(R) Reported To Be Safe And Effective In Study Published In European Journal Of Dermatology
09.07.2008 08:17
medicalnewstoday.com
ALIGN Pharmaceuticals, LLC, a wholly owned subsidiary of Cyclacel Pharmaceuticals, Inc., (NASDAQ: CYCC, CYCCP) announced results of a double-blinded, randomized, vehicle-controlled clinical study showing that Xclair® cream (formerly MAS065D) is safe and effective in the treatment and prevention of radiation dermatitis. These results were published in the May-June 2008 issue of the European Journal of Dermatology.
World
Dermatology
The ECNP Consensus Statement On Bipolar Depression
09.07.2008 08:17
medicalnewstoday.com
Bipolar disorder is one of the most complex and challenging mental disorder in the spectrum. Bipolar disorder is typically associated with considerable acute and longterm treatment needs and may be associated in the course of illness with times of tremendous social burden for both the individual and family. It is typically referred to as an episodic, yet lifelong and clinically severe mood disorder.
World
Depression
Patients More Likely To Stay On Lipitor Than Simvastatin, A Large Observational Study Shows
09.07.2008 08:17
medicalnewstoday.com
Pfizer announced that new statin users who took Lipitor® (atorvastatin calcium) were significantly more likely to stay on their medication compared to those who took simvastatin, according to an observational study of more than 186,000 patients in one of the largest U.S. managed care claims databases. The results were published in the July issue of Current Medical Research and Opinion.
World
Cardiology
Cancer And Tropical Disease Drug Discovery Aided By Insect Warning Colors
09.07.2008 08:17
medicalnewstoday.com
Brightly colored beetles or butterfly larvae nibbling on a plant may signal the presence of chemical compounds active against cancer cell lines and tropical parasitic diseases, according to researchers at Smithsonian's Tropical Research Institute in Panama. Such clues could speed drug discovery and provide insight into the ecological relationships between tropical-forest plants and insects that feed on them.
World
Cancer
First Twenty-Five Percent Of Subjects In Phase 2 Melanoma Clinical Trial Treated
09.07.2008 08:16
medicalnewstoday.com
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced today that the first twenty-five percent (20 of 80) of melanoma subjects have been treated in Provectus Pharmaceuticals' Phase 2 clinical trial of PV-10. Additional subjects are being evaluated for eligibility for entrance into the trial or are awaiting treatment at the two active centers in Brisbane and Sydney, Australia.
World
Cancer
pSivida Corp: BrachySil™ Phase IIb Pancreatic Cancer Trials Commence
09.07.2008 08:16
medicalnewstoday.com
pSivida Corp. (NASDAQ:PSDV)(ASX:PVA)(FF:PSI), a global drug delivery company announced that a Phase IIb clinical trial has commenced with BrachySil™ (P32 BioSilicon™) as a potential new brachytherapy treatment for inoperable pancreatic cancer. The first patient has received treatment at Guy's and St Thomas' NHS Foundation Trust in London.
World
Cancer
Awareness Of Epidemiology's Limitations Could Reduce Impact Of False-Positive Cancer Results
09.07.2008 08:16
medicalnewstoday.com
False-positive results are an inherent risk in cancer research, particularly in observational epidemiology studies. The frequency and impact of misleading results can be mitigated if researchers use more exacting standards when interpreting and reporting results, according to a commentary in the July 8 online issue of the Journal of the National Cancer Institute.
World
Cancer
News From The July 8 Journal Of The National Cancer Institute
09.07.2008 08:16
medicalnewstoday.com
Reductions in Iron Blood Levels Associated with Decreased Cancer Risk in Men with Peripheral Arterial Disease Men with peripheral arterial disease who participated in a randomized controlled trial in which their iron stores were reduced by blood drawing had a reduced incidence of cancer relative to men in the trial who did not undergo blood letting.
World
Cancer
Stanford Researchers Find Molecule That Kills Kidney Cancer Cells
09.07.2008 08:16
medicalnewstoday.com
Kidney cancer patients generally have one option for beating their disease: surgery to remove the organ. But that could change, thanks to a new molecule found by Stanford University School of Medicine researchers that kills kidney cancer cells. Ideally, the researchers said, a drug created from this molecule would help fight the life-threatening disease while leaving patients' kidneys intact.
World
Cancer
Changes In Doctors' Reimbursement Has Not Affected Access To Cancer Care
09.07.2008 08:16
medicalnewstoday.com
The Medicare Modernization Act of 2003, which reduced the amount of money doctors are reimbursed for the delivery of chemotherapy treatments, has not harmed patients' access to care in the way critics feared it might, according to a new study, led by investigators from the Duke Clinical Research Institute (DCRI). Researchers measured patient access to care by looking at the distance they traveled to be treated and the time that lapsed between diagnosis and initiation of chemotherapy.
World
Cancer
Aurora(R) Breast MRI Society Debuts The Journal Of Breast MRI
09.07.2008 08:16
medicalnewstoday.com
The Aurora® Breast MRI Society, a rapidly growing group of dedicated breast health specialists committed to advancing the use of cutting-edge dedicated breast MRI technology, debuted its inaugural issue of The Journal of Breast MRI. The Journal was produced as a platform for Society members to relay clinical information and best practices for the detection, diagnosis and management of breast disease.
World
Cancer
Risk Prediction For Breast Cancer Not Substantially Improved By Single-Nucleotide Polymorphisms
09.07.2008 08:16
medicalnewstoday.com
Recently identified genetic markers, called single nucleotide polymorphisms (SNPs), that are associated with a small but statistically significant increase in the risk of breast cancer do not appear to substantially improve the accuracy of existing models that use clinical factors to predict an individual's risk, according to a study in the July 8 online issue of the Journal of the National Cancer Institute.
World
Cancer
LifeCycle Pharma Announces Positive Topline Results From Phase II Clinical Study Of LCP-Tacro Once Daily In Stable Liver Transplant Patients
09.07.2008 07:14
medicalnewstoday.com
LifeCycle Pharma A/S (OMX:LCP) announced positive top-line results from a completed Phase II clinical study of LCP-Tacro tablets in stable liver transplant patients which are in line with earlier data announced for stable kidney transplant patients.
World
Transplantation
Lautenberg Statement On Ftc Proposal To End Deceptive Tar & Nicotine Ratings For Cigarettes
09.07.2008 07:14
medicalnewstoday.com
U.S. Senator Frank R. Lautenberg (D-NJ) has issued the following statement in response to the Federal Trade Commission's (FTC) announcement that it will seek to end the ability of cigarette companies to use deceptive tar and nicotine claims.
World
Smoking
English